Michael Robin Hale

This inventor holds 56 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Protein Kinase Inhibitors. Top assignees: Vertex Pharmaceuticals, Inc., Alkermes, Inc., The Aerospace Corporation. Active years: 1999-2026.

USPTO Granted Patents = 56 (Patent Applications = 9)

% Patents Active = 51.8

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 10 (Patent Applications = 9)

Average Co-Inventor Count = 3.9

ph-index = 18

Forward Citations = 1,083(Granted Patents)

Forward Citations (Not Self Cited) = 1,047(Dec 10, 2025)

Location History:

Roseville, CA (US) (1999)
Indianapolis, IN (US) (2005)
San Jose, CA (US) (2009)
Corbin, KY (US) (2023)
Port St. Lucie, FL (US) (2023)
West Hollywood, CA (US) (2023)
Bedford, MA (US) (2001 - 2024)

Company Filing History:

45 out of 1,167

Vertex Pharmaceuticals, Inc.

The Aerospace Corporation

patents

4. 4 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Protein Kinase Inhibitors

ERK Protein Kinase

Aspartyl Protease

Pyrrole Inhibitors

Sulfonamide Derivatives

Heterocyclic Compounds

Pyrazole-Derived Inhibitors

Triazole-Derived Inhibitors

Macrocyclic Compounds

Prodrugs

Selective Inhibitors

Lamp Assembly

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12637476 - Substituted carbamate macrocyclic compounds and related methods of treatment (2026-05-26),

2. 12054495 - Substituted macrocyclic compounds and related methods of treatment (2024-08-06),

3. 12006330 - Substituted macrocyclic compounds and related methods of treatment (2024-06-11),

4. 11784358 - Self regulating modular battery (2023-10-10),

5. RE49500 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto (2023-04-24),

6. 11598502 - Lamp platform assembly (2023-03-07),

7. 11564465 - Cane with a leg strap (2023-01-31),

8. 11542276 - Substituted macrocyclic compounds and related methods of treatment (2023-01-03),

9. RE48266 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto (2020-10-19),

10. RE47318 - Pyrrole inhibitors of erk protein kinase, synthesis thereof and intermediates thereto (2019-03-25),

11. RE46097 - Pyrrole inhibitors of ERK protein kinase, synthesis thereof and intermediates thereto (2016-08-08),

12. 8455497 - Inhibitors of aspartyl protease (2013-06-04),

13. 7919523 - Inhibitors of aspartyl protease (2011-04-05),

14. 7592368 - Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors (2009-09-22),

15. 7522822 - Halogen lamp assembly with integrated heat sink (2009-04-21),

Title: The Innovative Journey of Michael Robin Hale

Introduction:

Michael Robin Hale, a visionary inventor hailing from Bedford, MA, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Michael Robin Hale's latest patents include cutting-edge technologies in the fields of artificial intelligence, renewable energy, and biotechnology, showcasing his versatility and forward-thinking approach.

Career Highlights:

With over two decades of experience in the industry, Michael Robin Hale has a proven track record of transforming ideas into tangible inventions. His work has not only revolutionized existing technologies but has also paved the way for new advancements in various sectors.

Collaborations:

Throughout his career, Michael Robin Hale has collaborated with leading research institutions, top universities, and innovative companies to bring his ideas to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Michael Robin Hale's passion for innovation, coupled with his dedication to pushing the boundaries of technology, has established him as a prominent figure in the world of inventors. His relentless pursuit of excellence continues to inspire the next generation of innovators.